Based on this experience, the following patient 6 was treated with perampanel as an initial ASM when he was diagnosed with NR2F1-related epilepsy (DD, visual impairment, infantile spasm and WES presenting NR2F1 de novo variant). Here, NR2F1 is linked to epilepsy.